Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is drawing insider interest, particularly in oncology innovation, with insiders investing heavily in the company. Top executives purchased shares at $0.80 each, driven by confidence in the company’s potential, despite current share price dips to $0.59. The company
